Role of calpain in adipocyte differentiation
AUTOR(ES)
Patel, Yashomati M.
FONTE
The National Academy of Sciences
RESUMO
Evidence is presented that the calcium-activated protease, calpain, is required for differentiation of 3T3-L1 preadipocytes into adipocytes induced by methylisobutylxanthine (a cAMP phosphodiesterase inhibitor), dexamethasone, and insulin. Calpain is expressed by preadipocytes and its level falls during differentiation. Exposure of preadipocytes to the calpain inhibitor N-acetyl-Leu-Leu-norleucinal or overexpression of calpastatin, a specific endogenous inhibitor of calpain, blocks expression of adipocyte-specific genes, notably the CCAAT/enhancer-binding protein (C/EBP)α gene, and acquisition of the adipocyte phenotype. The inhibitor disrupts the differentiation-inducing effect of methylisobutylxanthine (by means of the cAMP-signaling pathway), but is without effect on differentiation induced by dexamethasone or insulin. N-acetyl-Leu-Leu-norleucinal, or overexpression of calpastatin, inhibits reporter gene expression mediated by the C/EBPα gene promoter by preventing C/EBPβ, a transcriptional activator of the C/EBPα gene, from binding to the promoter. These findings implicate calpain in the transcriptional activation of the C/EBPα gene, a process required for terminal adipocyte differentiation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=15454Documentos Relacionados
- Role of Foxa-2 in adipocyte metabolism and differentiation
- The CCAAT/enhancer binding protein and its role in adipocyte differentiation: evidence for direct involvement in terminal adipocyte development.
- Essential Role of Insulin Receptor Substrate 1 (IRS-1) and IRS-2 in Adipocyte Differentiation
- Repressive Effect of Sp1 on the C/EBPα Gene Promoter: Role in Adipocyte Differentiation
- Role of calpain in skeletal-muscle protein degradation